GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Equasens (STU:PHF) » Definitions » EV-to-EBITDA

Equasens (STU:PHF) EV-to-EBITDA : 0.00 (As of Jun. 01, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Equasens EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Equasens's enterprise value is €0.0 Mil. Equasens's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €37.1 Mil. Therefore, Equasens's EV-to-EBITDA for today is 0.00.

The historical rank and industry rank for Equasens's EV-to-EBITDA or its related term are showing as below:

STU:PHF's EV-to-EBITDA is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12.075
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-06-01), Equasens's stock price is €49.30. Equasens's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €3.114. Therefore, Equasens's PE Ratio (TTM) for today is 15.83.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Equasens EV-to-EBITDA Historical Data

The historical data trend for Equasens's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Equasens EV-to-EBITDA Chart

Equasens Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.15 30.40 22.27 16.35 13.13

Equasens Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 16.35 - 13.13 -

Competitive Comparison of Equasens's EV-to-EBITDA

For the Health Information Services subindustry, Equasens's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Equasens's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Equasens's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Equasens's EV-to-EBITDA falls into.


;
;

Equasens EV-to-EBITDA Calculation

Equasens's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=0.000/37.148
=0.00

Equasens's current Enterprise Value is €0.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Equasens's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was €37.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Equasens  (STU:PHF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Equasens's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=49.30/3.114
=15.83

Equasens's share price for today is €49.30.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Equasens's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €3.114.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Equasens EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Equasens's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Equasens Business Description

Traded in Other Exchanges
Address
5 Allee de Saint-Cloud, Technopole de Nancy Brabois, Villers-les-Nancy, FRA, 54600
Equasens is engaged in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) and patients in both primary and secondary care sectors. With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens is developing the healthcare platform and an ecosystem in France and Europe benefiting people by making available its technology services.

Equasens Headlines

From GuruFocus

Bulldog Investors Sniffs Out Value in the Pacholder High Yield Fund

By Kyle Ferguson Kyle Ferguson 04-14-2017